APA (7th ed.) Citation

Burkhard-Meier, A., Rechenauer, V. V., Jurinovic, V., Albertsmeier, M., Hoberger, M., Dürr, H. R., . . . Berclaz, L. M. (2025). First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: A retrospective single-center analysis. Journal of Cancer Research & Clinical Oncology, 151(4), 1. https://doi.org/10.1007/s00432-025-06208-8

Chicago Style (17th ed.) Citation

Burkhard-Meier, Anton, et al. "First-line Pazopanib in Patients with Metastatic Epithelioid Hemangioendothelioma: A Retrospective Single-center Analysis." Journal of Cancer Research & Clinical Oncology 151, no. 4 (2025): 1. https://doi.org/10.1007/s00432-025-06208-8.

MLA (9th ed.) Citation

Burkhard-Meier, Anton, et al. "First-line Pazopanib in Patients with Metastatic Epithelioid Hemangioendothelioma: A Retrospective Single-center Analysis." Journal of Cancer Research & Clinical Oncology, vol. 151, no. 4, 2025, p. 1, https://doi.org/10.1007/s00432-025-06208-8.